5Avritscher EB,Cantor SB,Shih YC,et al. Cost-minimization analysis of low-molecular-weight heparin (daheparin) compared to unfractionated heparin for inpatient treatment of cancer patients with deep venous thrombosis [J]. Support Care Cancer,2004,12 (7):531-536.
6Manuel M, Paolo P. Venous thromboembolism as first manifestation of cancer [J]. Seminars Thrombosis Hemastasis, 1999, 25 (2): 131-136.
7Sutherland DE,Weitz IC,Liebman HA. Thromboembolic complications of cancer: epidemiology, pathogenesis, diagnosis, and treatment [ J ]. Am J Hematol, 2003,72(1 ):43-52.
8Lyman GH et al. American Society of clinical oneology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer[J]. J Clin Oncol, 2007,25 (34):5490-5505.
